These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11315954)
21. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Tam NN; Chung SS; Lee DT; Wong YC Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807 [TBL] [Abstract][Full Text] [Related]
22. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
23. Multistage prostate carcinogenesis: the role of hormones. Bosland MC; Dreef-Van Der Meulen HC; Sukumar S; Ofner P; Leav I; Han X; Liehr JG Princess Takamatsu Symp; 1991; 22():109-23. PubMed ID: 1844235 [TBL] [Abstract][Full Text] [Related]
24. [Adjustive effect of yi qi tong lin chongji on the three growth factors in rats prostatic tissues]. Mi ZG; Liu SX; Cao YQ; Yang XF Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):653-5. PubMed ID: 15139114 [TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897 [TBL] [Abstract][Full Text] [Related]
26. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Powolny AA; Wang S; Carlton PS; Hoot DR; Clinton SK Mol Carcinog; 2008 Jun; 47(6):458-65. PubMed ID: 18058807 [TBL] [Abstract][Full Text] [Related]
31. Altered growth factor expression in the aging penis: the Brown-Norway rat model. Rajasekaran M; Kasyan A; Jain A; Kim SW; Monga M J Androl; 2002; 23(3):393-9. PubMed ID: 12002441 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Böcker-Meffert S; Rosenstiel P; Röhl C; Warneke N; Held-Feindt J; Sievers J; Lucius R Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2021-6. PubMed ID: 12037014 [TBL] [Abstract][Full Text] [Related]
33. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
35. Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis. Xie B; Tsao SW; Wong YC Breast Cancer Res Treat; 1999 Dec; 58(3):227-39. PubMed ID: 10718485 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Tian X; Song S; Wu J; Meng L; Dong Z; Shou C Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087 [TBL] [Abstract][Full Text] [Related]
37. Activation of NF-kappaB in association with prostate carcinogenesis in noble rats. Yatkin E; Bernoulli J; Santti R Ann N Y Acad Sci; 2006 Nov; 1089():282-5. PubMed ID: 17261776 [TBL] [Abstract][Full Text] [Related]
38. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio. Yatkin E; Bernoulli J; Talvitie EM; Santti R Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173 [TBL] [Abstract][Full Text] [Related]
39. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Song K; Cornelius SC; Danielpour D Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605 [TBL] [Abstract][Full Text] [Related]
40. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]